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Dear Editor,
The human T-cell lymphotropic virus type 1 (HTLV-1) was 
the first retrovirus identified in humans, and is the causal 
agent of HTLV-1-associated myelopathy (also known as 
tropical spastic paraparesis [HAM/TSP]) and adult T-cell 
leukemia/lymphoma (ATLL). HTLV-1 has been neglected 
mainly due to the misconception that it is a low morbidity 
viral infection. Recently evidence has been accumulating that 
a large percentage of HTLV-1-infected subjects, previously 
only considered as carriers, have disease due to the virus, 
such as sicca syndrome, chronic periodontitis, overactive 
bladder, erectile dysfunction, uveitis, and HTLV-1-associated 
arthropathy.1 
It is estimated that approximately 20 million individuals 
are infected by HTLV-1 worldwide; Brazil is considered to be 
the country with the highest number of cases. Epidemiologic 
studies have pointed out that HTLV-1 is documented in all 
states of Brazil.2 In this issue of the Revista Brasileira de 
Hematologia e Hemoterapia a seroepidemiologic study 
showed a prevalence of 0.15% of HLTV-1 infection among blood 
donors in the State of Maranhão.3 Moreover, there was a high 
percentage (68.6%) of co-infected individuals with hepatitis B 
virus (HBV). 
Epidemiologic studies performed over 20 years in Brazil 
have contributed to evaluate the changes in the prevalence 
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of HLTV-1 infection, and have been highly relevant to 
identify changes in the transmission pattern. In Salvador, the 
prevalence of the infection has decreased from 1987 to 2005.4,5 
Regarding the transmission pattern, breastfeeding has been 
considered the main route of viral transmission, followed by 
sexual contact and use of contaminated supplies by addicts. 
However, the study by Viana et al.3 in this issue confirmed 
previous findings from Mota et al.5 and Monteiro de Castro 
et al.,6 who demonstrated that seroprevalence increases with 
age. These data support the hypothesis that, rather than 
breastfeeding, other forms of transmission are currently more 
important in the acquisition of HTLV-1 infection. Moreover, 
the large percentage of co-infections with HBV is new and 
deserves special attention. HTLV-1 increases the susceptibility 
to other infectious agents such as Strongyloides stercoralis and 
Mycobacterium tuberculosis, and increases the severity of scabies 
and strongyloidiasis.1 While the high prevalence of HTLV-1 
and HBV co-infection may be due to changes in the pattern 
of transmission, it is important to determine whether HTLV-1 
may predispose or modify the natural course of HBV infection.
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